Novo CEO pressed by Senate to chop price ranges of obesity, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would think about new talks with insurers with regards to the record price ranges of Wegovy and copyright if they pledge to keep the medicines on their formularies. https://kethek.com/